MARKET

NRXP

NRXP

Nrx Pharmaceuticals Inc
NASDAQ
2.620
-0.090
-3.32%
After Hours: 2.630 +0.01 +0.37% 19:53 01/02 EST
OPEN
2.750
PREV CLOSE
2.710
HIGH
2.765
LOW
2.545
VOLUME
702.33K
TURNOVER
--
52 WEEK HIGH
6.01
52 WEEK LOW
1.430
MARKET CAP
77.57M
P/E (TTM)
-1.1283
1D
5D
1M
3M
1Y
5Y
1D
Ulta Beauty To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday
Benzinga · 14h ago
NRx Pharmaceuticals price target raised to $48 from $47 at Ascendiant
TipRanks · 17h ago
NRX Pharmaceuticals Is Maintained at Buy by Ascendiant Capital
Dow Jones · 17h ago
NRX Pharmaceuticals Price Target Raised to $48.00/Share From $47.00 by Ascendiant Capital
Dow Jones · 17h ago
Ascendiant Capital Maintains Buy on NRX Pharmaceuticals, Raises Price Target to $48
Benzinga · 18h ago
NRx Pharmaceuticals Completes Debt Repayment, Ends 2025 Debt-Free
TipRanks · 12/29/2025 22:06
NRX Pharmaceuticals Eliminates All Debt Through Equity Conversion
Reuters · 12/29/2025 21:31
Weekly Report: what happened at NRXP last week (1222-1226)?
Weekly Report · 12/29/2025 09:58
More
About NRXP
NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing therapeutics based on its N-methyl-D-aspartate (NMDA) platform for the treatment of central nervous system disorders, specifically suicidal depression, chronic pain, and PTSD. It is developing NRX-100 (preservative-free intravenous ketamine) and NRX-101, (oral D-cycloserine/lurasidone). NRX-100 has been awarded Fast Track Designation for the treatment of Suicidal Ideation in Depression, including Bipolar Depression. NRX-101 has been awarded Breakthrough Therapy Designation for the treatment of suicidal bipolar depression. NRx has filed an Abbreviated New Drug Application (ANDA) and initiated a New Drug Application filing for NRX-100 (IV ketamine) with an application for the Commissioner’s National Priority Voucher Program for the treatment of suicidal depression. Its subsidiary, HOPE Therapeutics, Inc., is a healthcare delivery company that is building a network of interventional psychiatry clinics.

Webull offers NRX Pharmaceuticals Inc stock information, including NASDAQ: NRXP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NRXP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NRXP stock methods without spending real money on the virtual paper trading platform.